In tumor xenografts of SULT2B1-RNAi-LV cells, cyclinB1, MYC and BCL2 protein levels decreased, while no significantly differences in cyclinD1 protein levels was observed between the two groups (Fig. 5E). This evidence concerns the gene BCL2 and neoplasm.